Patents by Inventor Chris Van Geet

Chris Van Geet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITION OF PACAP SIGNALLING FOR THE PREVENTION AND TREATMENT OF THROMBOCYTOPENIA
    Publication number: 20100129372
    Abstract: The present invention discloses the use of inhibitors and/or antagonists of PACAP signalling for the manufacture of a medicament for the prevention or treatment of decreased blood platelet numbers (thrombocytopenia).
    Type: Application
    Filed: August 31, 2009
    Publication date: May 27, 2010
    Inventors: Kathleen Freson, Chris Van Geet, Marc Hoylaerts
  • ANTI-VPAC1 ANTIBODIES AND THEIR USES
    Publication number: 20100104530
    Abstract: Monoclonal antibodies, in particular monoclonal antibodies to the VPAC1 receptor protein, compositions containing them and nucleic acid sequences encoding them. Host cells expressing said monoclonal antibodies, recombinant (expression) vectors and methods for producing said antibodies. Prevention or treatment of thrombocytopenia with antibodies to the VPAC1 receptor.
    Type: Application
    Filed: June 26, 2008
    Publication date: April 29, 2010
    Inventors: Kathleen Freson, Chris Van Geet, Marc Hoylaerts, Jean-Marie Stassen
  • Inhibition of PACAP signalling for the prevention and treatment of thrombocytopenia
    Patent number: 7615219
    Abstract: The present invention discloses the use of inhibitors and/or antagonists of PACAP signalling for the manufacture of a medicament for the prevention or treatment of decreased blood platelet numbers (thrombocytopenia).
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: November 10, 2009
    Assignee: Life Sciences Research Partners VZW
    Inventors: Kathleen Freson, Chris Van Geet, Marc Hoylaerts
  • Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia
    Publication number: 20060062785
    Abstract: The present invention discloses the use of inhibitors and/or antagonists of PACAP signalling for the manufacture of a medicament for the prevention or treatment of decreased blood platelet numbers (thrombocytopenia).
    Type: Application
    Filed: January 16, 2004
    Publication date: March 23, 2006
    Inventors: Kathleen Freson, Chris Van Geet, Marc Hoylaerts